Kymera Therapeutics, Inc. (KYMR)
72.93
-1.84
(-2.46%)
USD |
NASDAQ |
Jan 12, 12:05
Kymera Therapeutics Accounts Payable (Quarterly): 5.506M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 903.80M |
| Gilead Sciences, Inc. | 808.00M |
| Cytokinetics, Inc. | 22.08M |
| TG Therapeutics, Inc. | 112.34M |
| Protagonist Therapeutics, Inc. | 5.646M |